![]() market for "failed dissolution specifications". The drug firm is also recalling 16,449 bottles of Progesterone Capsules (200 mg), used to cause menstrual periods in women who have not yet reached menopause, in the U.S. The U.S.-based unit of the drug major initiated the nationwide recall on February 19, 2021, and the USFDA has categorised it as Class III recall which is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences". The Hyderabad-based firm is recalling the drug, which is used to prevent cardiovascular disease, for "failed impurities/degradation specifications", the USFDA said. Similarly, Dr Reddy's Laboratories is recalling 10,440 (90-count) and 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets in the U.S. The Princeton (NJ) based firm initiated the nationwide recall of the affected lot on February 22, this year, it added. The U.S.-based subsidiary of the Mumbai-based drug major is recalling 37,400 cartons (60 vials per carton) of the ophthalmic solution for being "subpotent", the U.S. Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye. market, the world's largest market for pharmaceutical products, for various reasons.Īs per the latest Enforcement Report by the U.S. Leading home grown drug makers Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |